ArticleCancer reports (Hoboken, N.J.)2023

Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft models.

Takahiro Nagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.